Matinas BioPharma Completes Enrollment in First Human Trial of MAT9001

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/3/2026

1. KRG
2. ALAR
3. CCH:LN
4. META
5. CCHGY
6. PRY:IM
7. PRYMY
8. SPY
9. SKA-B
10. PBA

Go back to Matinas BioPharma Completes Enrollment in First Human Trial of MAT9001
(NYSE: MTNB) Delayed: 0.63 --0 (-0%)
Previous Close $0.63    52 Week High $2.01 
Open $0.63    52 Week Low $0.41 
Day High $0.67    P/E N/A 
Day Low $0.62    EPS $0.00 
Volume 54,768